N-linked glycan compounds
US-9221898-B2 · Dec 29, 2015 · US
US8993536B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8993536-B2 |
| Application number | US-201013143129-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 1, 2010 |
| Priority date | Feb 2, 2009 |
| Publication date | Mar 31, 2015 |
| Grant date | Mar 31, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A low-molecular-weight polysulfated hyaluronic acid derivative useful for treatment of an allergic disease. An agent for treatment of an allergic disease selected from pollinosis, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, and asthma, represented by the following general formula (IA) or (IB); wherein n represents a number of 0 to 15; R's each independently represent a hydrogen atom or an SO3H group etc.
Opening claim text (preview).
The invention claimed is: 1. A method for treating an allergic disease, the method comprising: administering, to a human or an animal in need thereof, an effective dose of a low-molecular-weight polysulfated hyaluronic acid derivative of formula (IA) or (IB), or a pharmaceutically acceptable salt thereof: wherein n is from 1 to 15; X is of formula (a) or (b):…
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.